Sequoia Capital Warns Frothy Chinese Precision Medicine Market

Login to View

Although precision medicine has attracted great market attention and venture funding during the past two years, there are few Chinese start-ups with truly innovative technologies, warns Sequoia Capital’s partner Chen Penghui at the ChinaVenture Annual Conference.

Continue reading with a China Money Network subscription


Join Now

Already have an account or paid subscription? Log in


RELATED NEWS



LEAVE A REPLY

Please enter your comment!
Please enter your name here